A Vacca… - Multiple Myeloma, 2011 - Springer Abstract Angiogenesis plays a central role in the progression of both solid and hematologic tumors. We have focused our attention on mul- tiple myeloma (MM) and on bone marrow stromal cells. These, in fact, both support tumor cell survival and participate in angiogenesis by ... Cited by 2 - Related articles - All 3 versions
M Roussel, T Facon, P Moreau, JL Harousseau… - Multiple Myeloma, 2011 - Springer Abstract High dose therapy (HDT) with autol- ogous stem cell transplantation (ASCT) is the standard of care for eligible newly diagnosed MM patients. Several randomized studies dem- onstrated a survival advantage for patients undergoing transplantation, compared with con- ... Related articles - All 3 versions
RA Kyle… - Multiple Myeloma, 2011 - Springer Abstract Multiple Myeloma has been recognized since Ancient Times. The first well-documented case was reported in 1844 by Samuel Solly. The most commonly recognized case is that of Thomas Alexander McBean, a highly respectable trades- man from London in 1850. Mr. McBean ... Cited by 8 - Related articles - All 3 versions
T Moehler, H Goldschmidt - Multiple Myeloma, 2011 - Springer Abstract Despite considerable improvements in first line treatment still the majority of pati- ents experience relapse of multiple myeloma. Treatment decisions for relapse or refractory multiple myeloma should be based on a clinical decision path taking response and adverse ... Related articles - All 2 versions